For more information, visit Inova's website.
Program Director:Christopher M. O’Connor, MD, CEO, Inova Heart & Vascular Institute
Program Co-Director:Shashank S. Desai, MD, Medical Director, Advanced Heart Failure and Transplant, Inova Heart & Vascular Institute
Keynote Speaker:Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine atHarvard Medical School, and Chairman of the TIMI Study Group at the Brigham and Women’s Hospital
Eugene Braunwald, MD is considered the leading name in cardiology and his research has expanded knowledge and understanding in the areas of congestive heart failure, coronary artery disease, and valvular heart disease. He has authored more than 1400 medical articles and his textbook, Braunwald’s Heart Disease, is cited worldwide and recognized as the best book on the subject.
Dr. Braunwald has received numerous honors and awards including the Distinguished Scientist Award of the American College of Cardiology, Research Achievement, and Herrick Awards of the American Heart Association, the Gold Medal of the European Society of Cardiology and is the recipient of nineteen honorary degrees from distinguished universities throughout the world. Dr. Braunwald was the first cardiologist elected to the National Academy of Sciences of the United States. The living Nobel Prize winners in medicine voted Dr. Braunwald as "the person who has contributed the most to cardiology in recent years."
About This Event
AtInova Heart and Vascular Institute, we are dedicated to fostering an academic environment that will expand knowledge and, ultimately, improve patient outcomes. We are thrilled to announce the 2015 Advanced Heart Failure Symposium, an event for medical professionals who are eager to learn more about innovative practices and technologies in cardiovascular care.
We will hear from over 25 esteemed faculty who will cover areas such as Preventing Heart Failure and Readmissions, Novel Approaches to Heart Failure Management, Heart Failure Co-Morbidities, Advanced Heart Failure, and the Role of Biomarkers and Omics in Advanced Heart Failure.